This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
02/08/16 - 3:59:59 PM ET (BATS BZX Real-time Price)
Div Yield: --
INSY Day's Range
INSY 52 Week Range
INSY Business Summary
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products.View INSY
Insys Therapeutics Inc - INSY - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Insys Therapeutics Inc as a
Buy with a ratings score of B-.
Report Snippet: We rate INSYS THERAPEUTICS INC (INSY) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, increase in net income and good cash flow from operations. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself.